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Polymeric vesicles, or polymersomes, are nano- to micrometre sized polymeric capsules with a bilayered
membrane. Applications of these vesicles are foreseen in nanomedicine, in vivo imaging and drug
delivery. These applications put many restrictions on the choice of polymer, the size and the surface of
the vesicle. In this respect much can be learned and translated to polymersome science from lines of
research with a longer history of practical knowledge such as liposomal formulation and polymer drug
conjugation. The dimensions of a vesicle, such as size and shape can be controlled for polymersomes
and will influence the in vivo circulation time. The surface can be adjusted to induce stealth character, or
chemically modified to introduce targeting moieties. And last but not least the choice of block
copolymers—the building blocks of a polymersome—can introduce features like biocompatibility,
inherent or induced permeability and triggered release. In this review we will discuss the recent advances
in polymersome science with regard to biomedical applications and will specifically address the
abovementioned features which affect their biological behaviour.
1. Introduction
Polymeric vesicles, or polymersomes, are nano- to micrometre-
sized polymeric capsules with a bilayered membrane which is
comprised of amphiphilic block copolymers. Although the
aggregation behaviour of amphiphilic polymers was noticed
before,1–4 the first systematic study after the formation of poly-
mersomes was reported by Discher et al.5 In this paper the name
polymersomes was coined, in analogy to liposomes. When the
bilayer membrane architecture is regarded, the similarity
between polymersomes and liposomes is obvious in the sense that
both species are composed of a bilayer of amphiphiles enclosing
an aqueous compartment. There are however also major
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differences. The building blocks of liposomes are in most cases
naturally occurring phospholipids with a molecular weight well
below 1 kDa; a polymersome is constructed of amphiphilic block
copolymers with a molecular weight up to 100 kDa. This higher
molecular weight of the building blocks manifests itself in
a tougher, less permeable and less fluidic membrane and as
a result superior physical and chemical stability are obtained.
With regard to the use of high molecular weight building blocks
and the resulting robustness of the capsule structure one can
argue that polymersomes resemble to a certain extent viral
capsids6 and therefore can be an interesting candidate for in vivo
and cellular delivery.
Amphiphilic block copolymers have not only been found to
form vesicular structures; in fact, the formation of a bilayered
vesicular structure puts quite some restrictions on the overall
block copolymer composition. Depending on the ratio between
the hydrophobic and hydrophilic part of the polymer, spherical
micelles, rods and vesicles have been found to form spontane-
ously.7 Which morphology is found is dependent on the geom-
etry of the amphiphile, which can vary between cylindrical and
conical depending on the ratio of the hydrophobic and hydro-
philic segments. For small molecular weight amphiphiles this
geometry is captured in the dimensionless packing parameter8,9
as is depicted in Fig. 1, which can to some extent also be trans-
lated to polymeric amphiphiles. More intuitively, however, the
hydrophilic fraction (f) is better suited to predict the expected
morphology.6,7 Block copolymers with a hydrophilic fraction of
more than 45–50 percent will mostly yield micelles. In the region
where f is around 35  10 percent in many cases polymersomes
are observed and in case the hydrophilic fraction is less than 25
percent, inverted structures can be expected. Finally, there is
a small region where worm-like micelles have been reported,
when the hydrophilic fraction is around 50 percent. Although
this basic empirical rule holds quite well in most cases, the exact
aggregation behaviour can depend strongly on the type of block
copolymer and the conditions applied.
Polymersomes have been prepared in a variety of different
ways. Among them two methods seem to be favoured. First of all
the ‘‘solvent switch’’ method is broadly applied.10,11 The block
copolymer is dissolved in an organic solvent which is a good
solvent for both blocks. The organic solvent is diluted with or
injected in a non-solvent of one of the blocks, mostly water or
a buffered solution, until the desired aggregates are formed.
Residual organic solvents are removed by dialysis or are allowed
to evaporate. One of the major drawbacks is the need of an
organic solvent which is not always compatible with applications
in which bioactive compounds have to be encapsulated.
Furthermore, traces of the organic solvents tend to stay behind
which is not desirable for in vivo applications. The second general
method is a technique based on rehydration.11 A polymer film is
cast on a substrate and an aqueous solution is used to rehydrate
the polymer to form vesicles. Furthermore, methods like elec-
troformation, bulk rehydration and rehydration from pre-
treated substrates have been applied. The choice of the method of
formation has a big influence on the properties such as the size of
the obtained vesicles.
Vesicles are thought to form in a two-step procedure. In an
early stage of formation a flat bilayer is formed from micelles or
polymer clusters, as depicted in Fig. 2a and b. Thereafter under
the influence of a curvature change, and therefore a change in the
packing parameter, this sheet will form a closed structure or
a vesicle.12,13 This mechanism is depicted in the cartoon presented
in Fig. 3. This sequence of events leads to statistical encapsula-
tion of compounds dissolved in the water layer, but it does not
provide an explanation for the many fascinating shapes found
experimentally.12 More recent simulation studies show the
possibility of an alternative, more complex, mechanism in which
vesicles do not evolve from the closing of a bilayer membrane,
but evolve from micelles that grow and change morphology.13,14
It should be noted that for the second pathway the loading
efficiency of hydrophilic compounds would be lower compared
to the former one since there is no closure, and hence encapsu-
lation step involved. Experimentally, polymersome formation
along path I is supported by Du and Chen15 (Fig. 2). They were
Fig. 1 Several structures formed by the self-assembly of amphiphilic
block copolymers as determined by the geometry of the amphiphile. The
geometry is captured by the dimensionless packing parameter p ¼ v/
(a0lc).
9 Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced
with permission.
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able to trap and visualize transition states like micelles and
lamellae that eventually formed polymersomes by systematically
adjusting the solvent polarity and locking the structure chemi-
cally prior to transmission electron microscope (TEM) imaging.
Experimental evidence for the second route was found by Adams
et al.16 They showed how indeed poor loading efficiencies for
hydrophilic compounds were found. These two seemingly con-
tradictive experimental results show that it is possible that more
mechanisms of formation do exist, depending on the exact
conditions applied.13
The field of polymersome research has been reviewed exten-
sively in the past6,9,11,17–24 and often the high potential of poly-
mersomes for biomedical applications such as smart drug
delivery systems, in vivo imaging vehicles or artificial organelles is
mentioned. Many of these applications involve cell specific
interactions and/or require non-toxic and tuneable in vivo
behaviour, and these criteria put quite some restrictions on e.g.
the choice of polymer and the polymersome dimensions. In this
review we address specifically the factors that affect the use of
polymersomes in biomedical applications. In the next sections we
will focus on which components are suitable for the construction
of polymeric vesicles for this specific field of application. We will
furthermore address the importance of size, topology and tune-
able stability and permeability. Finally, a selection of function-
alization methods will be discussed. In addition we will illustrate
these topics with recent research and try to extrapolate facts from
liposomal research and apply them on polymersomes.
2. Block copolymers
The starting point of formation for any polymersome is the
amphiphilic diblock or triblock copolymers that are the building
blocks of the membrane. More than a decade of research into
polymeric vesicles not only yielded some understanding under-
lying the formation of block copolymer nanostructures, but also
allowed researchers to use their full creativity in the synthesis of
new amphiphilic polymers. This resulted in an extensive library
of block copolymers known today to form aggregates. For
a comprehensive overview of polymers used for polymersome
formation, one is referred to some recent reviews on biohybrid
amphiphiles23 and synthetic amphiphilic block copolymers.9,25
This section will focus on the most common types of polymers
used in biomedical polymersome research.
For biomedical applications it is obligatory to use biode-
gradable or at least biocompatible polymers as building blocks.
The field of polymer drug conjugates has already a long history
of practical knowledge on suitable polymers that are in clinical
use/evaluation nowadays.26,27 These polymers include synthetic
polymers such as poly(ethylene glycol) (PEG), poly-
(N-(2-hydroxypropyl)methacrylamide) (pHPMA), poly(vinyl
pyrrolidone) (PVP) and poly(ethylene-imine) (PEI), but also
natural polymers like dextran, dextrin and pseudosynthetic
polymers such as poly-L-glutamic acid (PGA) and poly(L-lysine)
are commonly used. The translation from polymer drug conju-
gates to polymersome-forming amphiphilic block copolymers is
not always straightforward, but many examples can be found in
literature in which biocompatible and bio-inspired block
copolymers have been employed to form polymeric vesicles.
2.1 Synthetic polymers
The first well-studied polymersome-forming system was based on
the biocompatible block copolymer poly(ethylene oxide)-b-poly-
(ethyl ethylene) (PEO-b-PEE).5Although the PEE block is highly
biocompatible, it is the PEO block that gives these polymersomes
useful in vivo characteristics. The water-soluble poly(ethylene
oxide) (PEO) or poly(ethylene glycol) (PEG) is a polymer which
is generally known for its good biocompatibility and excellent
in vivo behaviour. Application of a PEG mantle is used in lipo-
some formulations to strongly reduce in vivo and in vitro non-
specific protein adsorption, resulting in stealth behaviour and
therefore prolonged circulation times.28,29 PEG has been coupled
to many hydrophobic blocks such as the non-degradable poly-
styrene (PS) and polybutadiene (PBd),30 or biodegradable poly-
mers such as polycaprolactone (PCL) or poly(lactic acid)
(PLA).31–33 Each hydrophobic polymer introduces specifically
desired characteristics in the polymersome. Polystyrene as an
example has a relatively high glass transition temperature (Tg)
and will yield after removal of the organic solvent a rigid semi-
crystalline membrane. Polybutadiene on the other hand has a Tg
well below room temperature which will result in a flexible and
fluidic membrane which allows for extrusion and therefore size
control after polymersome formation. Polymersomes of poly-
butadiene-b-polyethylene glycol (PBd-b-PEG) are generally
considered as fully biocompatible and are therefore popular in
research toward in vivo applications like drug delivery. However,
polybutadiene is not biodegradable, at least not on the timescale
Fig. 2 Several stages of polymersome formation captured by Du and
coworkers15 as a function of water/organic solvent ratio. First spheres
and rods are formed that transform into lamella which close to form
polymersomes due to an increase in water content.
Fig. 3 Cartoon of polymersome formation along path I as described by
Antonietti et al.12 First spheres that transform into sheets are formed
which close in a second step to form polymersomes. Copyright Wiley-
VCH Verlag GmbH & Co. KGaA. Reproduced with permission.
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of days. PCL and PLA on the other hand are biodegradable and
biocompatible and are therefore also often encountered as the
hydrophobic block.30–33
Instead of using the neutral and inert PEG block as a hydro-
philic element, also some more functional moieties can be
applied. The most straightforward way is to introduce ionic
character in a block copolymer. In this way the water-soluble EO
block was replaced for polyacrylic acid (PAA) to introduce
negatively charged acid residues,34 but also the zwitterionic,
phospholipid mimic, poly(2-methacryloyloxy-ethyl phosphor-
ylcholine) (PMPC) has been applied as the hydrophilic block by
Armes and co-workers.35–37 They furthermore showed how
polymersomes with interesting pH-dependent properties are
obtained if both blocks contain zwitter-ionic or ionisable
monomers as is the case with vesicles prepared from poly-
(2-(diisopropylamino)ethyl methacrylate) (PDPA) as the
hydrophobic and PMPC35 as the hydrophilic block. The PDPA
block is hydrophobic at pH above 6.4 but readily becomes
hydrophilic and protonated below this pH. This results in a sharp
transition from polymersomes to free dissolved block copoly-
mers upon lowering the pH, which can be used as a drug release
mechanism.
The previous example involved an external stimulus (pH
change) to release the content from the vesicle, but also amphi-
philic block copolymers with inherently leaky properties have
been reported. Polymersomes of polystyrene-b-poly3-(isocyano-
L-alanyl-aminoethyl) thiophene (PS–PIAT) turned out to be
excellent candidates for nanoreactors, since these polymersomes
are permeable for small molecules whereas large molecules such
as enzymes stay trapped inside.3,38 Although not fully under-
stood, this permeability is probably a result of the helical rodlike
secondary structure of the hydrophilic PIAT block, which frus-
trates the packing of the polymers in a closed bilayer.
These selected examples already show a few of the many
possibilities to alter and tune the characteristics of the poly-
mersomes, like robustness, charge and permeability. One crucial
property however remains biocompatibility and/or biodegrad-
ability. It is therefore a logical step that many researchers have
developed amphiphilic block copolymers capable of forming
polymersomes which are partly based on naturally occurring
building blocks such as amino acids, nucleotides and
carbohydrates.
2.2 Bio(hybrid) polymers
Oligo- and polypeptides are highly versatile and biodegradable
polymersome building blocks, since their properties can be
varied in many different ways. A wide variety of secondary
structures can be created based on the primary sequence of
amino acids. By selecting the correct amino acid residues stim-
ulus-responsive behaviour is introduced, such as a pH dependent
charge and hence solubility.39 One of the first reports on the
formation of vesicular structures from peptide hybrids made use
of an antibacterial hydrophobic helical peptide, Gramicidin A.
By coupling Gramicidin A with PEG an amphiphilic block
copolymer was obtained40 which readily formed a variety of
aggregated structures in aqueous solution. Among the obtained
structures a vesicle-like aggregate was found, which was called
a peptosome.2,41 Since then the name peptosome has been more
generally used for peptide-containing polymersomes. This early
example involved a hydrophobic peptide which was buried under
a PEG mantle. However, in most other cases the peptide moiety
is the hydrophilic part, forming the periphery of the vesicles. This
was for example demonstrated by Dirks et al.42 who coupled
a tri-peptide, Gly–Gly–Arg–AMC, via the copper-catalysed
azide–alkyne Huisgen [3 + 2] cycloaddition to polystyrene. Even
more common than the use of oligopeptides is the application of
polypeptides as building blocks in polymersome-forming block
copolymers. Peptides consisting of a repetition of the same
amino acid, and block copolymers of homopolypeptides can
nowadays be obtained in a controlled fashion by the polymeri-
sation of N-carboxyanhydrides (NCA) with a nickel catalyst and
an amine initiator.43,44 In this way PBd was used as the amine
functional initiator to polymerize for example PBd–poly-
(L-glutamate)45–48 and PBd–poly(L-lysine)49 which both have
been extensively studied with respect to their aggregation
behaviour. These examples involve a combination of synthetic
polymers and polypeptides, but also block copolymers of which
both the hydrophobic and the hydrophilic part are composed of
polypeptide hybrids that have been designed to form polymer-
somes.39,50,51 In two recent examples Kimura et al. showed the
usefulness of peptosomes for in vivo cancer imaging.52 They
constructed peptosomes out of a block copolymer composed of
poly(N-methylglycine) and poly(g-methyl-L-glutamate) (PMLG)
in which a near infrared dye was encapsulated. These peptosomes
showed good in vivo circulation times and low recognition by the
reticuloendothelial system (RES) (blood clearance mostly by
liver and spleen).
Another group of naturally occurring building blocks which
have recently gained more attention are carbohydrates or poly-
saccharides.22,53–55 In natural systems saccharides are conjugated
to the surface of cells via the lipids that make up the cell
membrane (glycolipids), and they are also found conjugated to
proteins (glycoproteins). These glycoconjugates play an impor-
tant role in biological processes such as cellular recognition and
pathogen infections. In many cases these processes are mediated
via interactions between saccharides and receptor proteins, called
lectins. In general lectins have only a low affinity for saccharides,
so this needs to be compensated by multivalent interactions via
the so-called cluster glycoside effect. Application of (poly)
saccharides in polymersomes as the hydrophilic part of block
copolymers or as the end group of block copolymer amphiphiles
allows for the construction of highly functionalised and multi-
valent vesicle surfaces.
Although quite some research has focused on the synthesis of
polysaccharide block copolymers not many examples have been
reported that actually form polymersomes.22 An example which
also demonstrates specific recognition is a fairly simple rod–coil
amphiphile, tetra(p-phenylene)-block-PEG12-a-D-mannopyr-
anoside.56 This molecule formed small polymersomes which
specifically interacted with the pili of a specific Escherichia coli
bacterial strain as depicted in Fig. 4. When the head group was
replaced for galactose, polymersomes were still formed, but
without the binding properties. Another example involved a b-
cyclodextrin head group coupled to PS which also formed vesi-
cles.57 The hydrophobic interior of b-cyclodextrin was used to
attach hydrophobic fluorescent dyes and the adamantane-
coupled enzyme horseradish peroxidase (HRP) to the surface.
1452 | Polym. Chem., 2011, 2, 1449–1462 This journal is ª The Royal Society of Chemistry 2011
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Block copolymers comprising polysaccharides such as
dextran-b-poly(benzyl-L-glutamate) (PBLG)53 dextran-b-PS and
hyaluronan-b-PBLG58 have also been used for vesicle formation.
In these cases polymeric vesicles were obtained via the solvent
switch method. Furthermore, dextran-b-PS was found to form
both micelles and vesicles, depending on the PS length. The
usefulness of these peptide–carbohydrate hybrid polymersomes
in drug delivery was nicely demonstrated in a series of recent
papers by Lecommandoux et al.59–61 They prepared doxorubicin
loaded hyaluronan-b-PBLG polymersomes and showed both
in vivo and in vitro (tumor)-targeting by the hyaluronan
periphery as well as release and shrinkage of the tumors in animal
models. Finally, an elegant first example of a thermoresponsive
saccharide-containing block copolymer was reported by Otsuka
et al.62 They coupled maltoheptaose (mal7) to poly(N-iso-
propylacrylamide) (PNIPAM) via click chemistry to obtain
polymersomes. They showed how above the lower critical solu-
tion temperature (LCST) of PNIPAM polymersomes were
spontaneously formed whereas below the LCST the assemblies
were dissolved again.
2.3 Polymeric vesicles with non-bilayer structure
There is also a group of vesicle-forming polymers which strictly
speaking do not yield a bilayer structure. An interesting example
is the self-assembly into vesicles of ABA or ABC triblock
copolymers.63 Although the overall composition is similar to
a vesicle bilayer: namely two hydrophilic outer blocks separated
by a hydrophobic inner domain, the entire structure is a single
layered vesicle. By changing the blocks A, B or C one can even
direct the orientation of the polymers in the membrane, thereby
obtaining asymmetric membranes that display different
functional groups on the inside and outside as was elegantly
demonstrated by W. Meier and co-workers. Very recently Percec
et al.64 reported an in depth investigation into a variety of
amphiphilic or Janus dendrimers that formed a variety of
aggregates, among them a vesicular structure that was named
dendrimersomes. A peptidic-dendron polymersome was also
reported to form polymersome-like structures.65 Another inter-
esting system is the so-called polyion polymer complex or PIC-
some.66–70 They are based on two polymers with opposite charges
that self-assemble and phase separate into vesicular structures
This is an example of a series of polymers that recognize each
other and form recognition-induced aggregates, the so called
RIP’s.71–73 A final example of vesicles that do not exhibit
a bilayered membrane was developed by Caruso et al.74 They
showed how enzymes can be entrapped in vesicles that were
formed by a layer-by-layer deposition of anionic and cationic
polymers.
3. Structural factors
For in vivo and biomedical applications of polymersomes it is
important to ascertain that a particle circulates for sufficient time
to reach the place where it is wanted. This can be achieved by
protecting the particle from interactions with the immune
system. We have already mentioned examples of polymers that
exhibit such stealth-like behaviour which was attributed to the
PEG surface of the particles. It should be noted however that
although PEGylation is a good start to rule out non-specific
interactions, it is by itself not enough to escape clearance by the
RES. Although not all factors influencing in vivo circulation
times have been fully investigated yet for polymersomes, the
analogy between polymersomes and liposomes allows for some
extrapolation.
From liposome research it is known that factors like stealth-
like behaviour, size and shape play an important role.75,76
Therefore this section will review how to control these parame-
ters. Furthermore we will highlight some research where these
effects have been observed.
3.1 Stealth-like behaviour
To prolong blood circulation time and prevent recognition by the
RES a PEG mantle is applied in liposomal formulations by
introducing up to ten percent PEGylated phospholipids. PEG
has very useful characteristics in the sense that it blocks (almost
all) non-specific protein adsorption and induces no immune
response, basically giving a vessel stealth characteristics.28,29
These stealth liposomes have blood circulation half times in the
order of 15 hours and will circulate in traceable amounts for
many days. Discher and coworkers investigated the in vivo fate of
polymersomes formed from PBd–PEG by preparing polymer-
somes with a fluorescent dye entrapped.77,78 These polymersomes
were inherently hundred percent PEGylated. The blood circu-
lation half life was determined by counting fluorescent dots in
blood samples derived at different time points. Compared to
PEGylated liposomes the circulation half life was found to be
even longer and polymersomes could still be found after several
days. These results show that PEGylated polymersomes also
have stealth-like behaviour. It should be noted that not only
Fig. 4 Rod coil amphiphile which forms small vesicles. The man-
nopyranoside head group induces recognition and binding to the pili of
Escherichia coli. Replacing this moiety for galactose had no influence on
the aggregate formation, but resulted in loss of recognition.56
This journal is ª The Royal Society of Chemistry 2011 Polym. Chem., 2011, 2, 1449–1462 | 1453
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PEG has the useful characteristics of reducing interaction with
opsonins and preventing clearance by the reticuloendothelial
system (RES). Also the zwitterionic polymer PMPC has been
recognized to reduce the adsorption of opsonins.79 Other possi-
bilities might be found with pHPMA, and oligosaccharides such
as cyclodextrin might be used since these polymers are already
under investigation as polymer-conjugated therapeutics.26
Finally in liposomal formulations poly(oxazoline) conjugates
also showed prolonged circulation times.80 The non-adsorptive
character and hydration shell of the hydrophilic mantle is
obligatory to create stealth-like particles, but it is certainly not
enough.
3.2 Size
Although not fully investigated for polymeric vesicles it is known
from liposome science that size has a big influence on blood
circulation times, RES recognition, biodistribution and the
mechanism of cell uptake.75,81 Fig. 5 shows a literature compi-
lation by Harashima et al. on how the circulation time of lipo-
somes is influenced by the size of the liposome. What is not clear
from this picture is that there is also a lower limit for prolonged
circulation times. The junctions in vascular endothelium of
healthy tissue vary depending on the tissue type. In most tissues
these openings are below 2–6 nm, so too small for liposomes and
polymersomes to enter. Organs and tissues with discontinuous
endothelium like the fenestrated endothelium of kidney
glomerulus or sinusoidal endothelium of the liver and spleen can
have pores of 40–60 and up to 150 nm.82 Particles with a size
below these values will therefore be excreted or trapped within
the tissue resulting in clearance from the circulation. It is notable
that tumors can have discontinuous microvasculature with pore
sizes above 100 nm. In fact, this is the basis for non-targeted
delivery to tumors since particles that are small enough to enter
will accumulate in the tumor. Taking these mechanisms into
account the optimum size for circulation in the blood stream is
expected to be around 80–150 nm. It might be expected that
a similar trend is valid for polymersomes and the polymersome
size should be controlled to achieve optimal blood circulation
half lives.
For polymersomes the eventual vesicle size can be influenced
at different points in the process of preparation. The first level to
exert influence is on the polymer level. For example, it has been
shown that there is correlation between amphiphile molecular
weight and aggregate size.83 Furthermore, the polydispersity10 of
the block copolymer and the ratio between blocks can have an
influence on the size distribution.
One stage further, one can influence the size using different
methods of vesicle formation.84 Rehydration methods and
solvent displacement85 or injection86 methods have been applied
and mostly yield 50 to 800 nanometre-sized polymersomes. On
the other hand electroformation will yield micrometre-sized giant
polymersomes. Howse et al.84 recently showed how they were
able to use surface-directed templating with different mesh
surfaces to influence the size of PEO–PBO vesicles. They were
able to deposit block copolymer domains of predefined size on
a grid and showed how rehydration from these grids yielded
control over polymersome size as depicted in Fig. 6. Smaller
polymer domains yielded smaller polymersomes (5–10 mm) with
in all cases small size distributions. The presence of pH-respon-
sive, ionizable groups can also allow control over size during
vesicle formation by changing the pH or ionic strength.48 A
certain amount of control over polymersome size was shown by
Shen and Eisenberg.87 They were able to influence the vesicle size
by changing the solvent nature and composition during solvent
displacement formation of PS–PAA polymersomes. Luo and
Eisenberg85 showed how also binary organic solvent systems can
be used to influence the size. Furthermore the presence of addi-
tives like dendrimers,88 (homo)polymers10 and surfactants89 have
been shown to influence the average polymersome size and
polydispersity.10
Finally polymersomes can be resized after they have been
formed. In this respect the most straightforward way to obtain
polymersomes of a predefined size is by extrusion. This basically
means that a preformed sample of polymersomes is pressed
through a filter with nanopores.78 This procedure has also been
proven to be applicable on larger scale by the use of hollow
nanofibers.90The only restriction is that the polymeric membrane
should remain fluidic till the end of the procedure, therefore
polymers with a low Tg are needed. In the stage after formation it
is also possible to exert influence on the size via more sophisti-
cated methods than extrusion. Eisenberg and co-workers
reported how membrane fusion and fission driven by a change in
dioxane/water content (change of interfacial energy) allowed
vesicles to grow and shrink reversibly.85,87
Fig. 5 Compilation of literature by Harashima and Kiwada75 on the
effect of particle size on the blood clearance of liposomes.
Fig. 6 Rehydration of amphiphilic block copolymers from a surface
template. The dimensions of the polymer domain (L) dictate the eventual
polymersome size (dmax).
84 (i) Block copolymer domain of predefined
dimensions, (ii) hydration and phase separation, (iii) further hydration
and lamellae formation, (iv) expansion, (v) detachment and (vi) energy
minimalisation resulting in polymersome formation.
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Another example involves the swelling of the membrane by an
external stimulus. In this way pH-responsive blocks have been
introduced in the corona to trigger size change, but also a change
in secondary structure of polypeptides has been employed.45 In
a recent example by Yu et al.91 the formation of so-called
‘‘breathing vesicles’’ from PEO–PS–PDEA was demonstrated.
By variation of the pH they were able to swell and shrink the
polymersome (membrane) with a factor of 1.9 changing
simultaneously the membrane permeability as depicted in Fig. 7.
This approach shows how a well-chosen balance between solu-
bility and hydration will keep the aggregate together but still
allows considerable changes. If this balance is not carefully
chosen, the polymersome will probably disassemble into its
polymeric constituents.
3.3 Shape
The influence of shape and topology on in vivo behaviour is not
so well studied for liposomes and polymersomes. In fact, prob-
ably the most illustrative example for the influence of shape in
amphiphilic assemblies for in vivo behaviour comes from rod like
micelles as studied by Geng et al.92 They showed how worm-like
micelles, which are nonspherical in nature, have blood circula-
tion times exceeding those of spherical particles like liposomes
and polymersomes by far even if the persistence length at the
moment of injection is several microns. Micelles or worm-like
micelles93–95 do not have an aqueous lumen and therefore do not
allow for delivery of hydrophilic compounds, but also worm-like
polymersomes have been observed and described96,97 that do
enable the encapsulation of hydrophilic compounds, and which
should have similar behaviour.
These cylindrical shapes are not the only non-spherical shaped
vesicles that have been reported. In fact a realm of non-spherical
aggregates is possible.12 This has already been demonstrated for
giant phospholipid vesicles (10–50 mm) of which it is known that
they can transform shape from spherical into a variety of
nonspherical shapes upon a change in their environment.98,99
Theoretical studies on triblock copolymers by Li et al.100 showed
that this transformation should also be possible for polymer-
somes as depicted in the phase diagram in Fig. 8.
Recently, experiments have been performed in which non-
spherical polymeric assemblies were created chemically15 or via
kinetic entrapment.101 It should therefore be possible in the near
future to investigate the effect of shapes other than rodlike or
spherical on in vivo behaviour.
4. Release and permeabilisation mechanisms
One of the advantages of polymersomes over liposomes is their
more robust and therefore less leaky membrane, which is very
useful for improved circulation times and the prevention of
uncontrolled release of drugs. However, at one point almost each
in vivo application involves a disruption step to release the vesicle
content or make the content accessible. Despite the fact that
polymersomes display improved stability, many successful
examples exist of stimuli–responsive vesicles, which release their
contents upon action of an external trigger.8,19,23 It is also
possible to achieve permeability control, i.e. controlled pore
formation, without complete disruption of the vesicular struc-
ture. In the next section we will highlight a few recent and
illustrative examples.
4.1 Triggered disruption
The most straightforward example of a release mechanism is
actually degradation of the biodegradable polymers of which the
vesicle is composed. Polymersomes of PCL-b-PEG released their
cargo due to biodegradation based on (pH driven) hydrolysis of
the polymers. During this process a transformation change from
polymersomes to rods and eventually micelles was in some cases
observed due to the change in hydrophilic fraction (f). By mixing
Fig. 7 Reversible change of the PEG-b-PS-b-PDEAMA membrane
upon pH change. (A) Cryo-TEM images of the vesicle wall structure at
several pH values. (B) Schematic illustration of the presumed membrane
structure at corresponding pH values.91
Fig. 8 Morphologies possible for triblock copolymers as determined
theoretically by Li et al.100
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in a stable PBd-b-PEG block copolymer it was possible to tune
the speed of degradation.6,30 Besides hydrolysis also disruption
based on chemical alteration of the block copolymer by oxida-
tion97 or reduction have been reported,19 pH-triggered release
mechanisms which in principle are reversible have also been
reported. A nice example of a polymersome that can disassemble
upon a pH change was already encountered in Section 2.1.
Armes and coworkers used the biocompatible zwitterionic
PMPC-b-PDPA block copolymer to form polymersomes at pH
above six. By lowering the pH a sharp transition was observed
from vesicles to molecularly dissolved polymers due to proton-
ation of the PDPA block. The polymersome content was thereby
instantaneously released. The driving force for polymersome
formation is in most cases based on phase separation due to the
amphiphilic character of the block copolymer. By switching the
character of the hydrophobic block to hydrophilic it is possible to
dissolve the whole polymersome and release the content.
Recently Kim et al.102 reported a system based on this principle.
They developed a stimulus-responsive amphiphilic polymer
containing boronic acid moieties in the hydrophobic domain
that, upon increase of pH and in the presence of mono-
saccharides such as D-glucose, became soluble in an aqueous
environment. Another interesting example was reported by
Lecommandoux. They prepared polymersomes of a block
copolymer comprising two polypeptides, poly-L-glutamate-b-
poly-L-lysine (PGA-b-PLys). By changing the pH they were able
to switch the solubility of both blocks, effectively flopping the
whole membrane.103 Those examples all involve a change in pH
as the trigger, but there are more stimuli explored.
Also changes in temperature can be used for altering the
hydrophilicity of a block copolymer.19 From literature there are
quite some polymers, peptides and proteins which demonstrate
LCST behaviour as was mentioned before in section 2.2 with the
example by Otsuka et al.62 Fig. 9 shows another very versatile
example based on P(DEAEMA98-b-NIPAM392), a so-called
‘‘schizophrenic’’ polymer.104,105 This system was shown to actu-
ally reversibly dissolve and assemble into polymersomes, as well
as transform micelles to polymersomes based on either a pH and/
or a temperature trigger.104 Based on a pH-induced conforma-
tional change Bellomo et al.39 reported a release mechanism for
polymersomes composed of a dipeptide block copolymer which
contained a stable hydrophilic a-helix of PEGylated poly-
L-lysine and a hydrophobic a-helix of poly(L-leucine0.3-co-L-
lysine0.7). Upon lowering the pH the a helix of the hydrophobic
block transformed into a random coil due to protonation of the
lysine residues. This conformational change was found to disrupt
the vesicle, allowing the transport of calcium ions and dyes in and
out of the polymersome.
Researchers also have developed methods of disruption, based
on external stimuli such as ultrasound and light. An interesting
system was reported by Mabrouk et al.106 as depicted in Fig. 10.
They described how the incorporation of azobenzene moieties
allowed for a conformational change in the membrane upon
illumination with UV light. Their polymersomes were disrupted
within a second. Fig. 11 shows another example of a light-driven
vesicle shape transformation and release. Robbins et al.107
reported how polymersomes formed from PBd-b-PEG with
porphyrins entrapped in the membrane and proteins in the lumen
disrupted in response to light. When either the protein or the
porphyrin was left out this effect was negligible, indicating
a synergy between the fluorophore and the encapsulated enzyme.
4.2 Controlled permeability
For some applications a complete disruption of the vesicle is not
desired. Rather, the polymersome should be semi-permeable.
This is for example the case in enzyme therapeutics or artificial
organelles, in which enzymes are encapsulated in the vesicle. The
polymersome functions as a protective cage, i.e. keeping the
enzymes in and allowing substrate and products to diffuse in and
out of the polymersome. Different strategies have been reported
on how to create in a controlled fashion these semi-permeable or
leaky polymersomes.
An example of an inherently leaky polymersome is based on
the earlier mentioned PS-b-PIAT block copolymer system. These
polymersomes have been used as biocatalytic reactors, by
encapsulating enzymes in the lumen. It was shown that substrate
diffused through pores in the membrane, and the encapsulated
enzyme was not able to escape, basically making it a nanoreactor
with a semi-permeable membrane.38 This line of research was
developed further by creating a nanoreactor108 capable of per-
forming a three-enzyme cascade reaction. The cascade scheme is
depicted in Fig. 12 and shows how one enzyme is entrapped in
Fig. 9 Mechanism of aggregation and dissolution of schizophrenic
vesicles as described by Smith et al.104
Fig. 10 Polymersome disruption by illuminating with UV light. A
fraction of the polymeric building blocks is functionalized with azo-
benzene moieties. Illumination with light induced a conformational
change, disrupting the polymersome and releasing its content.106
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the lumen, a second is captured in the hydrophobic membrane
and finally a third enzyme is coupled covalently to the surface via
clickable anchors. Another system that has been reported by
Kataoka to assemble in a semi-permeable membrane is based on
oppositely charged block copolypeptides which yield PIC-
somes.70 These PICsomes have also been used as biocatalytic
nanoreactors. Although these two examples show the usefulness
of semi-permeable vesicles, in both cases the permeability was
not tuneable.
Meier and co-workers followed a bio-inspired approach for
the construction of semi-permeable vesicles.109 They nicely
showed that bacterial transmembrane channel proteins OmpF
and aquaporin110,111 could be successfully reconstituted into the
membrane of polymersomes composed of the triblock copolymer
poly(2-methyl oxazoline)-b-poly(dimethyl siloxane)-b-poly-
(2-methyl oxazoline) (PMOXA–PDMS–PMOXA), which made
these vesicles selectively porous. In nature many transmembrane
pores have a directed orientation, but upon reconstitution into
liposomes or polymersomes they tend to adopt a random
orientation, basically blocking out fifty percent of the channels.
By using an asymmetric ABC type of triblock copolymer they
were able to form vesicles with either the A or the C block on the
outside,111 effectively constructing an asymmetric membrane as
depicted in Fig. 13. They reconstituted aquaporin 0 in these
membranes and were able to tune the direction insertion. An
elegant approach towards the construction of semi-permeable
polymersomes112 was the reconstitution of LamB protein in
PDMS-b-PMOXA polymersomes. This protein was recognized
by bacteriophage lambda and used to dock the phage, after
which it injected its DNA into the polymersome, as nicely
captured by TEM imaging in Fig. 14.
In another example Choi andMontemagno113 showed that it is
also possible to reconstitute two different proteins, bacterio-
rhodopsin and F1-ATP-ase, in a polymeric vesicle membrane, as
depicted in Fig. 15. ATP-ase can be regarded as a proton
gradient driven motor that, while rotating, converts ADP into
ATP. As noted ATP-ase needs a proton gradient to work. This
gradient is supplied by bacteriorhodopsin, which is activated by
a light source. Choi and coworkers nicely showed how the
enzymes worked together. If no light was applied there was no
production of ATP. This research is one of the first systems
reported where a complex biocatalytic process is performed in
a polymersome nanoreactor.
Only few examples of synthetic approaches towards controlled
semi-permeable polymersomes have been reported. One of the
first of these approaches was reported by Tsourkas and co-
workers.114 They designed polymersomes based on PBd-b-PEG
and mixed in phospholipids, 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-choline (POPC). After they crosslinked the PBd
membrane POPC was extracted leaving a porous vesicle. The
same method was applied by exchanging POPC for the
Fig. 11 Polymersomes loaded with enzymes in the lumen and porphy-
rins in the membrane respond to light by a morphology change and
eventually release of content.107
Fig. 12 Polymersome nano-reactor performing an three enzyme cascade
reaction. All three enzymes are associated with the PS–PIAT vesicle and
leaving out one will stop the whole cascade.108 Copyright Wiley-VCH
Verlag GmbH & Co. KGaA. Reproduced with permission.
Fig. 13 Asymmetric polymersome membranes obtained from ABC tri-
block copolymers allow for the directed reconstitution of transmembrane
channels.111 By changing the molecular weight of the A and C block either
the A or the C block is directed outwards. Copyright Wiley-VCH Verlag
GmbH & Co. KGaA. Reproduced with permission.
Fig. 14 Schematic and TEM image of a polymersome in which
membrane protein LambB is reconstituted.112 This membrane protein is
recognized by bacteriophage lambda which is shown to dock on the
polymersome to inject its RNA.
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biodegradable block copolymer poly(caprolactone)–PEG. After
crosslinking and hydrolysis a highly permeable polymersome was
obtained.115 Recently, another fully synthetic approach to
controlled permeable polymersomes was reported by Kim
et al.116 They used the boronic acid based block copolymers
described in Section 4.1 and mixed it with PS–PEG, which forms
a semi-crystalline membrane. Upon washing away the boronic
acid polymer by applying sugar and base they were able to form
pores in the membrane of which the size was tuneable by the ratio
of boronic acid block copolymer and PS–PEG. This procedure
could be used in combination with the encapsulation of CalB,
allowing the substrate to pass the membrane while keeping CalB
enclosed. They also showed how bigger pores allowed faster
diffusion of substrate, as determined by the reaction rate.
5. Surface functionality
PEGylated liposomes are neutral and are considered to be long
circulating vesicles, with circulation times up to days. When
compared to natural systems there is however room for
improvement. Red blood cells for example circulate up till
100 days. Their cell surface has an overall negative charge due to
the external glycocalyx moieties. For liposomes the effect of
surface charge has therefore been studied, but the general trend is
not so obvious and seems to be influenced by the size of the
liposome, especially in rat and mice studies.75 In rabbits a clear
trend was observed which was in favour of neutral PEGylated
liposomes (t1/2 ¼ 19.3 h), whereas negative and PEGylated
negatively charged liposomes showed circulation half times of
only 9.6 and 16.5 hours respectively.117 Charge is only one of the
possible functionalities which affect the interaction of polymer-
somes with biological systems. Another aspect is surface
topology. Research on both will be discussed in the next sections.
5.1 Surface topology
Christian et al.118 recently reported on the synthesis and in vivo
evaluation of polymersomes with a red blood cell like surface (i.e.
negatively charged surface). They prepared polymersomes of
PBd-b-PEG with a near infrared dye entrapped, and compared
them with polymersomes where a fraction of PBd-b-PAA was
introduced to obtain a negative surface charge. After 24 hours
they showed how polymersomes with negative surfaces
predominantly accumulated in the liver. Liposomes often are
covered with up to ten percent of PEG chains that induce stealth
character. In general it is thought that the conformation of the
surface PEG chains has an influence on the stealth effect. PEG
chains can either adopt a mushroom conformation to cover the
full surface or a fully stretched conformation depending on the
available space. Smart et al.119 studied these conformations for
polymersomes both theoretically and experimentally. For poly-
mersomes it is not so straightforward to reduce the number of
PEG chains in the corona. Often PEG is a part of the block
copolymer, covalently linked to the hydrophobic block and it is
needed to form and stabilize the polymersome in solution. By the
introduction of a hydrazone bond between PS and PEG (PS–Hz–
PEG) He et al.120 showed how polymersomes constructed of this
polymer were able to shed off their PEG mantle by adjusting the
pH. Brinkhuis et al.121 used this concept on PBd–Hz–PEG vesi-
cles and systematically mixed in a non-hydrolysable analogue.
They showed that after vesicle formation the number of PEG
chains could be reduced to five percent without losing the
colloidal stability. This is already an example where the surface
structure is adapted, but more complex surface topologies have
also been reported, involving domain formation.
In liposomes it is possible to create surface domains viamicro-
phase separation either assisted or not assisted by the addition of
ions.122 This domain formation was recently also described in
polymersomes.123 The effect of more complex surface topologies
on cell interactions was shown by Battaglia et al.124 They were
able to create domains within the polymersome surface by mix-
ing different ratios of two triblock copolymers based on PMPC.
They nicely showed how the ratio of polymers influenced the size
and number of domains present in their polymersomes as
depicted in Fig. 16. Furthermore, this figure indicates how the
cellular uptake is influenced by the surface topology and size of
these patchy polymersomes, pointing out the importance of
surface topology.
5.2 Surface functionalisation
In many biomedical applications reported thus far, such as in vivo
imaging, polymersomes have been used which contained a func-
tional content, e.g. near infrared fluorescent dyes52,118,125 and
MRI contrast agents,114,115 but which did not have any surface
functionality. In fact, they were mostly designed for prolonged
in vivo circulation times, which means that they were predomi-
nantly PEGylated. However, for imaging and drug delivery it
might be desirable to functionalize the periphery with ligands or
moieties that allow (specific) recognition. In principle two
approaches can be followed for this purpose. In the first method
the functional group is attached to the polymer prior to vesicle
formation. One of the first examples of this approach was the
Fig. 15 Light driven nanoreactor. Under the influence of light bacte-
riorhodopsin (BR) establishes a proton gradient, which is used by ATP-
ase to produce ATP from ADP.113
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preparation of a functionalized polymersome for cellular delivery
via the conjugation of the cell penetrating peptide Tat to PBd–
PEG. After the polymersomes were formed they showed good
cellular uptake and were able to deliver a near infrared dye
loaded polymersome to dendritic cells.125 However this approach
is not always trivial. If the functionality that needs to be intro-
duced is too hydrophobic, the moiety might fold back in the
membrane upon polymersome formation, reducing its avail-
ability. Furthermore, if bigger moieties need to be introduced,
this will put quite some restrictions on the preparation methods
and also the expected behaviour of the amphiphiles. Therefore
researchers have also developed a second approach which entails
post-functionalization of polymersomes either via covalent or via
strong non-covalent interactions, as recently reviewed by Meier
and coworkers.24
In many cases non-covalent interactions are reversible and this
can be useful, but also makes the system less robust. A non-
covalent interaction that is almost as strong as a chemical bond is
the interaction between biotin and streptavidin.126 Hammer and
co-workers127 used polymersomes of PBD–PEG end-function-
alized with biotin (actually biocytin) to study the adhesiveness of
these polymersomes to streptavidin, both surface immobilized
and free in solution. They showed that when biotin was attached
to a longer PEG chain than the non-functionalized membrane
polymers there was a difference in adhesive properties. When
biotin sticks out of the membrane the adhesion to immobilized
streptavidin increased whereas in solution no difference was
found. The group of Meier published a series of papers where
they used biotin-functional polymers to adhere polymersomes to
streptavidin.128,129 In one example130 they used a double bio-
tinylated triblock copolymer PMOXA–PDMS–PMOXA to
adhere biotinylated ligands to the surface. In this case strepta-
vidin with four binding sites fulfilled the function of effectively
connecting the polymersome and targeting ligand. The fact that
streptavidin has four binding sites also puts some restrictions on
its applicability. If the concentration of streptavidin becomes too
high crosslinking of polymersomes will become dominant and
bigger aggregates will form. The interaction of cyclodextrin and
adamantane is another example of a host–guest pair that
strongly interacts and of which one of the binding partners can
be easily immobilized on the surface of a polymeric
membrane.57,131
An interesting, strong, metal ion complexation that is often
used in protein science to purify proteins from a cell lysate is the
nickel–NTA interaction with histidine-tags. The group of Meier
showed two132,133 examples where they immobilized the NTA
ligand on the surface of PBD–PEG polymersomes. They
demonstrated to be able to complex both green fluorescent
protein (GFP) and bone morphogenetic protein (BMP) via their
His-tags on the polymersome surface.
Functional moieties have also been attached covalently to
premade polymersomes. However, there are some restrictions to
the chemistry involved. In most cases polymersomes are formed
and used in an aqueous environment, so the chemistry should be
applicable in water and be selective. A recent report134 on the
immobilisation of polymersomes on a substrate exploited
peripheral aldehydes to form an imine bond, which is in principle
reversible. An irreversible bond that can be formed and is
common in bio-conjugation techniques is the amide bond.
Carboxylic acids present on the periphery of polymersomes were
activated as NHS esters32 which allowed the attachment of
several proteins via available amine residues. Another coupling
strategy adopted from bioconjugation is the use of the maleimide
functionality. Maleimides readily react with thiols which can be
made available in a controlled fashion in both peptides and
proteins by the introduction of a cysteine residue. In this way
Pang et al.135 showed how they were able to couple mouse-anti-
rat monoclonal antibodies for brain delivery in rats to the surface
of polymersomes.
As depicted in Fig. 17 Opsteen et al.136 reported the use of the
copper-catalysed [2 + 3] Huisgen cycloaddition to immobilise
fluorescent dansyl, GFP and biotin on the surface of azide end-
functional PS–PAA vesicles. PS–PAA was easily synthesised via
ATRP and the introduction of the azide moiety was achieved by
substitution of the bromine end group present after ATRP. Not
all block copolymers however allow for easy modification.
Therefore, van Dongen et al.137 adopted a strategy in which they
mixed in up to ten percent of an acetylene-functional PS–PEG in
their PS–PIAT polymersomes. These so-called anchors allowed
for the immobilisation of enzymes on the vesicle surface. In order
to steer away from the toxic Cu catalyst, in recent years also
strain-promoted copper-free click reactions have been devel-
oped.138 Other click strategies have also been adopted. Very
recently Petersen et al.139 introduced the vinyl sulfone moiety in
polymersomes. This moiety also reacts fast and selective with
thiols. They showed how via this method RGD peptides could be
coupled on the periphery of their poly(methyl caprolactone)-b-
PEG polymersomes.
Beside the use of surface functionalisation to improve drug
delivery or in vivo imaging, it has also been employed to improve
on the cellular uptake of the polymersome nanoreactors as dis-
cussed in section 4.2.
Fig. 16 (a) Effect of the ratio of PMPC–PDPA and PEG–PDPA on the
domain size of patchy polymersomes. (b) The number and size of
domains influence the cell binding and uptake of patchy polymer-
somes.124 Copyright Wiley-VCH Verlag GmbH & Co. KGaA. Repro-
duced with permission.
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A first report of such an artificial organelle inside a cell was
provided by Ben-Haim et al.140 They showed how PMOXA–
PDMS–PMOXA polymersomes functionalized with oligonucle-
otide polyguanylic acid (polyG) are efficiently recognized by
macrophages and engulfed. A selection of other cell types did not
show significant cell uptake, underlining the specificity for
macrophages. After assessing the fate and distribution of the
polymersomes inside the macrophages they loaded the newly
constructed organelle with trypsin, an intestinal protease, and
delivered it to the cell. As a traceable substrate they chose the
hydrophobic tripeptide serine protease specific substrate BZi-
PAR (bis-(CBZ-Ile-Pro-Arg)-R110), which can diffuse passively
through both cell membranes and the polymeric membrane. First
they blocked the cell’s own protease to prevent false positives.
After the substrate reached the polymersome loaded trypsin in
the cell, the substrate was converted to release the coupled
Rhodamine effectively making the cells fluorescent.
In a more recent example van Dongen et al.138 used the
inherently semi-permeable polymersome based on PS-PIAT to
construct an artificial organelle. They ligated the cell penetrating
peptide Tat to the surface of their polymersomes to induce
cellular uptake by HeLa cells. The enzyme horseradish peroxi-
dase (HRP), which was encapsulated in the polymersome,
subsequently catalysed the oxidation of compound
3,30,5,50tetramethylbenzidine (TMB) by hydrogen-peroxide. The
oxidation product of TMB was easily detected and showed good
conversion inside the cell. This model reaction was used to
demonstrate that the artificial organelle was capable of neutral-
izing oxidative species in a cellular environment.
Conclusion
Polymersomes are new versatile carriers that have high potential
for in vivo imaging and nanotherapeutics. Although quite
different from liposomes general aspects known from liposomal
science can be used to design polymersomes with specific func-
tions. Control can be exerted over size, shape, surface function
and topology, which will influence the in vivo circulation time and
therefore the applicability of these nanocarriers. A large variety
of examples can nowadays be found in literature that show how
polymersome research has caught up with liposomal science in
the past decade and in many cases adds extra dimensions to what
is possible.
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